Odonate

Odonate Net Debt per Share

The Net Debt per Share of Odonate (ODTC) as of Oct 16, 2026 is -52.51 USD. In the previous year, Net Debt per Share was -43,395.45 USD — a change of -99.88% (higher).

Net Debt per Share

-52.51USD

YoY

-99.88%

Last updated:

Net Debt per Share of Odonate is 2023 -52.51 USD. Net Debt per Share of Odonate was 2022 -43,395.45 USD. It decreases by -99.88% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Odonate Stock analysis

What does Odonate do? Odonate Inc, based in San Diego, US, operates in the Health Care sector within Pharmaceuticals. The company develops therapeutics focused on improving and extending the lives of cancer patients, particularly through its oral chemotherapy agent tesetaxel. Tesetaxel has completed Phase-II studies for metastatic breast cancer, offering a low pill burden and simplified dosing regimen. Odonate employs 137 full-time staff and is listed on the stock market since December 7, 2017. Odonate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Odonate stock

Net Debt per Share of Odonate is -52.51 USD in 2023.

Net Debt per Share of Odonate changed from -43,395.45 USD to -52.51 USD, representing a -99.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Odonate since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Odonate

All Key Metrics — Odonate